A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.
| Current Price | $0.06 | Mkt Cap | $6.62M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 0.00 |
| Prev. Close | $0.06 | Div. (Yield) | N/A (N/A) |
| Daily Range | $0.05 - $0.06 | Volume | 0 |
| 52-Wk Range | $0.03 - $0.27 | Avg. Daily Vol. | 0 |
| Subject | Recs | Author | Date |
|---|
The best Bull and Bear pitches based on recency and number of recommendations.
This stock is a real sleeper.
I'm definitely running against the grain on this one but I don't think the phase III trial of onconase will be positive. Phase III trials which are the result of data mining from other failed phase III trials do not have a good track record. Since… More
Read the most recent pitches from players about ACEL.PK.
Recs
HAE3
(21.99)
Submitted: 3/24/2008 2:10:47 PM :
Start Price:
$2.40
ACEL.PK Score:
-100.33
This stock is a real sleeper.
Recs
Quoinintl
(< 20)
Submitted: 1/24/2008 6:15:33 PM :
Start Price:
$2.60
ACEL.PK Score:
-100.09
fda approval...oncanase!!
Recs
SAVERITELIQ
(< 20)
Submitted: 1/24/2008 4:45:30 PM :
Start Price:
$2.60
ACEL.PK Score:
-100.09
History will be made. New cancer drug finishing successful Phase III trials, hopefully will get FDA approval before end of 2008.
Low float, no gaps to fill, just successfully tested the 200 day moving average.
Find the members with the highest scoring picks in ACEL.PK.
j55555 (< 20) Score: +94.02
The Score Leader is the player with the highest score across all their picks in ACEL.PK.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| j55555 | < 20 | 7/30/2007 |
|
3W | $2.24 | -97.10% | -3.08% | +94.02 | 0 Comment | |
| jmbailey2000 | 66.08 | 4/20/2007 |
|
1Y | $2.42 | -97.31% | -4.11% | +93.20 | 0 Comment | |
| seraph0 | < 20 | 9/13/2007 |
|
5Y | $2.18 | -97.02% | -4.79% | +92.23 | 0 Comment | |
| Ernbo6 | 62.17 | 5/8/2007 |
|
3Y | $2.63 | -97.53% | -5.50% | +92.03 | 0 Comment | |
| SueMe100 | 46.71 | 6/4/2007 |
|
3W | $2.52 | -97.42% | -7.48% | +89.94 | 0 Comment | |
| Flark44 | 32.59 | 7/18/2007 |
|
NS | $2.49 | -97.39% | -8.33% | +89.06 | 0 Comment | |
| In2lose | < 20 | 7/19/2007 |
|
NS | $2.49 | -97.39% | -8.87% | -88.52 | 0 Comment | |
| Megalomania | < 20 | 6/20/2007 |
|
3M | $2.21 | -97.06% | -7.23% | -89.83 | 0 Comment | |
| Ratifyer | 58.78 | 6/1/2007 |
|
1Y | $2.85 | -97.72% | -7.69% | -90.03 | 1 Comment | |
| olemt | 28.80 | 7/6/2007 |
|
1Y | $2.43 | -97.33% | -7.18% | -90.14 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
